HUNAN DAJIAWEIKANG PHARMACEUTICAL INDUSTRY CO.,LTD

Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd

301126

CNE1000054V3

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 23/06/2024 BST			5-day change	1st Jan Change
8.47 ^CNY	-5.15%		-5.47%	-35.00%

06-05	Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd commences an Equity Buyback for CNY 15 million worth of its shares, under the authorization approved on April 15, 2024.	CI
05-22	Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024	CI

Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Approves Cash Dividend for 2023

May 15, 2024 at 08:33 pm

Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd announced at the AGM held on May 14, 2024 approved cash dividend/10 shares (tax included) of CNY 0.40000000 for 2023.

Latest news about Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd

Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd commences an Equity Buyback for CNY 15 million worth of its shares, under the authorization approved on April 15, 2024.	06-05	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024	05-21	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Approves Cash Dividend for 2023	05-15	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	04-22	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd announced that it expects to receive CNY 119.999994 million in funding	03-27	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	24/10/23	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Approves Board Elections	11/10/23	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd signed the share acquisition agreement to acquire 51% stake in Shanxi Simaile Pharmaceutical Chain Co., Ltd. from Yang Jinjiang, Liu Hongming for approximately CNY 330 million.	18/09/23	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd agreed to acquire Yinchuan Meihetai Pharmaceutical Chain Co., Ltd. from Xie Huiyang and Xie Xiaolong for approximately CNY 250 million.	03/07/23	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Implements Final Cash Dividend of A Shares for the Year 2022, Payable on June 12, 2023	02/06/23	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Approves Final Cash Dividend for 2022	15/05/23	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd cancelled the transaction announced on May 18, 2022	27/04/23	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd announced that it expects to receive CNY 300 million in funding	27/04/23	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Proposes Final Cash Dividend for the Year 2022	24/04/23	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	21/04/23	CI
Hunan Tongjian Pharmacy to Buy 86% Stake in Local Peer For 341 Million Yuan	03/01/23	MT
Hunan Tongjian Pharma to Buy 86% of Local TCM Maker For 341 Million Yuan	23/12/22	MT
Certain A Shares of Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd. are subject to a Lock-Up Agreement Ending on 8-DEC-2022.	07/12/22	CI
Hunan Dajiaweikang Pharma to Buy 85.7% Stake in Pharma Firm	16/11/22	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd signed a Share Transfer Agreement to acquire a 85.7143% stake in Hunan Tianjicaotang Pharmaceutical CO.,LTD. from Weng Xiaotao and Xiang Zhongyou for CNY 340 million.	15/11/22	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	25/10/22	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd completed the acquisition of 51% stake in Ningxia Delixin Medicine Co., Ltd. from Duan Junzhang, Duan Xisheng and Zhao Xupeng.	09/08/22	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	29/07/22	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd agreed to acquire 51% stake in Ningxia Delixin Medicine Co., Ltd. from Duan Junzhang, Duan Xisheng and Zhao Xupeng for approximately CNY 140 million.	21/07/22	CI

Chart Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd

Duration

Period

Chart Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd

More charts

Hunan Dajiaweikang Pharmaceutical Industry Co Ltd is a China-based company mainly engaged in the distribution and retail business of drugs, biological products, medical devices and other products. The Company is also engaged in reproductive hospital business. The pharmaceutical distribution business includes pure sales mode and allocation mode, mainly engaged in anti-tumor drugs, immunomodulatory drugs, cardiovascular and cerebrovascular drugs, respiratory drugs, antiviral drugs and other new and special drugs. The pharmaceutical retail business is mainly engaged in professional pharmacies, focusing on the sales of prescription drugs, mainly including Special Service pharmacy business and direct to patient (DTP) pharmacy business. The reproductive hospital business is mainly engaged in the diagnosis and treatment of gynecological and urological diseases.

Sector

Pharmaceuticals

Calendar

28/07/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
HUNAN DAJIAWEIKANG PHARMACEUTICAL INDUSTRY CO.,LTD	-35.00%	241M
MCKESSON CORPORATION	+30.55%	78.4B
CARDINAL HEALTH, INC.	+2.31%	25.12B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+12.73%	8.62B
SINOPHARM GROUP CO. LTD.	+1.71%	8.55B
HUADONG MEDICINE CO., LTD	-30.63%	6.91B
H. LUNDBECK A/S	+17.58%	5.34B
GALENICA AG	+2.75%	4.17B
EBOS GROUP LIMITED	-9.01%	3.82B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+9.64%	3.26B